Dennis Watson to Prostatic Neoplasms
This is a "connection" page, showing publications Dennis Watson has written about Prostatic Neoplasms.
Connection Strength
0.794
-
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate. 2011 Dec; 71(16):1723-35.
Score: 0.239
-
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther. 2008 Jan; 8(1):33-42.
Score: 0.191
-
CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability. Cancer Res. 2005 Jul 15; 65(14):6228-36.
Score: 0.161
-
ETS2 function is required to maintain the transformed state of human prostate cancer cells. Oncogene. 1998 Dec 03; 17(22):2883-8.
Score: 0.102
-
Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells. Nucleic Acids Res. 2004; 32(14):4358-67.
Score: 0.038
-
Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer. Int J Oncol. 2003 May; 22(5):1033-43.
Score: 0.034
-
Defects of DNA mismatch repair in human prostate cancer. Cancer Res. 2001 May 15; 61(10):4112-21.
Score: 0.030